Navigation Links
Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
Date:10/12/2011

CHAPEL HILL, N.C., Oct. 12, 2011 /PRNewswire/ -- The medical education landscape has changed dramatically for the pharmaceutical sector. As regulatory and market pressures have reshaped approaches to Continuing Medical Education programs, pharmaceutical organizations are struggling to have the right staffing, investment, and delivery platforms to provide valuable education opportunities for healthcare practitioners. 

To help inform medical education leaders on current approaches to medical education group size, service-levels, resources, and program deployment, Best Practices®, LLC conducted a new study, "Professional Medical Education Excellence: Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups." The study - which provides segments for both pharmaceutical and medical device leaders - presents medical education leaders' perspective on current and future trends for staffing and investment.

The study also informs education leaders on trends in the use of technology for education, the presence of education in emerging markets and how education groups are allocating their budget.

The research project found that on-demand Medical Education programs have proven popular in both pharma and device sectors as it offers busy physicians the flexibility to choose their timing for education. Almost 60 percent of the pharmaceutical segments' education programs in the past year were either on-demand or online Webcasts, according to the study.

This 85-page study covers the following topics:

  • Organizational Fit & Geographic Focus
  • Staffing Benchmarks & Program Trends
  • Roles for Key Activities & Program Deployment
  • Budget Benchmarks & Allocation Trends
  • Trends & Directions

The research project included observations and insights from 40 leaders with 35 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 10 medical device firms and 26 leaders from 25 biopharma companies. To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1127.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
2. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
3. Study Shows That Roches Investigational Drug for Alzheimers Disease Removes Amyloid Plaques From the Brain
4. Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh
5. Hologic Announces Six-year Follow-up Results from the MammoSite Targeted Breast Irradiation Registry Study
6. Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study
7. FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law
8. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
9. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
10. Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival
11. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
Breaking Medicine News(10 mins):